Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet aggregation in hyperapobetalipoproteinemia.

M Miller1, W Bell, S Plano

  • 1Lipid Research Atherosclerosis Unit, Johns Hopkins University School of Medicine, Baltimore, Maryland.

American Journal of Hematology
|July 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Improved Constraints on Primordial Gravitational Waves using Planck, WMAP, and BICEP/Keck Observations through the 2018 Observing Season.

Physical review letters·2021
Same author

Constraints on Primordial Gravitational Waves Using Planck, WMAP, and New BICEP2/Keck Observations through the 2015 Season.

Physical review letters·2018
Same author

Improved Constraints on Cosmology and Foregrounds from BICEP2 and Keck Array Cosmic Microwave Background Data with Inclusion of 95 GHz Band.

Physical review letters·2016
Same author

The spectrum of onset of acute kidney injury in premature infants less than 30 weeks gestation.

Journal of perinatology : official journal of the California Perinatal Association·2016
Same author

Joint analysis of BICEP2/keck array and Planck Data.

Physical review letters·2015
Same journal

Luspatercept Induces Significant Improvement in Anemia in Dominant Thalassemia Secondary to Heterozygous STEAP3 and Beta-Thalassemia Trait.

American journal of hematology·2026
Same journal

POEMS Syndrome: 2026 Update on Diagnosis, Risk-Stratification, and Management.

American journal of hematology·2026
Same journal

EIF2AK1 As a Key Genetic Determinant of Luspatercept Resistance in Transfusion-Dependent Thalassemia.

American journal of hematology·2026
Same journal

Subtotal Versus Total Splenectomy in Children With Sickle Cell Disease: Clinical Outcomes and Splenic Function Assessed by Pocked Red Blood Cell Count.

American journal of hematology·2026
Same journal

High Proportion of PNH Type II Neutrophils Is Associated With Thrombosis in Patients Displaying a PNH Clone ≥ 1.

American journal of hematology·2026
Same journal

Peripheral Blood Lymphocytosis Reflecting an Underlying Thymoma.

American journal of hematology·2026
See all related articles

Hyperapobetalipoproteinemia (HyperapoB), a lipid disorder linked to early heart disease, does not show abnormal platelet function. Platelet aggregation tests in hyperapoB subjects were similar to controls, suggesting this is not a contributing factor.

Area of Science:

  • Lipidology
  • Cardiovascular Medicine
  • Hematology

Background:

  • Hyperapobetalipoproteinemia (HyperapoB) is a lipid disorder associated with premature coronary artery disease.
  • The underlying mechanisms linking HyperapoB to coronary thrombosis remain unclear.
  • Platelet function abnormalities are a potential contributor to thrombotic events.

Purpose of the Study:

  • To investigate platelet aggregability in individuals with HyperapoB.
  • To determine if altered platelet function contributes to the increased risk of coronary thrombosis in HyperapoB.
  • To compare platelet lipid composition and aggregation responses in hyperapoB subjects versus controls.

Main Methods:

  • Platelet aggregation was assessed in hyperapoB subjects and healthy controls.

Related Experiment Videos

  • Aggregation was measured in response to standard agonists: epinephrine, ADP, and collagen.
  • Platelet lipid composition was analyzed for both groups.

    • Main Results:

    • No significant differences were observed in platelet lipid composition between hyperapoB subjects and controls.
    • Platelet aggregation responses to epinephrine, ADP, and collagen were comparable between the two groups.
    • These findings indicate normal platelet function in the context of HyperapoB.

    Conclusions:

    • Platelet function does not appear to be significantly altered in hyperapobetalipoproteinemia.
    • Unlike other dyslipidemias, abnormal platelet activity is unlikely to be a primary mechanism driving coronary thrombosis in HyperapoB.
    • Further research may focus on other pathways contributing to cardiovascular risk in this lipid disorder.